Importantly, IFNα treated subjects exhibited a significant correlation between increases in UWS and improvement in a number of the symptoms of Sjögren's syndrome, including oral dryness, throat dryness, nasal dryness and the ability to swallow foods. Here, IFNA1 is linked to Sjogren syndrome.